# ClinicalTrials.gov record NCT01430104

> PeptideScanner retained ClinicalTrials.gov record NCT01430104 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-01-14, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct01430104-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2013-01-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01430104-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01430104-teriparatide-v1.json
- Content SHA-256: `43e0fdb06dec61d0527694f79c4aa249dc2239e99efeed0352fa8f2f73d39854`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01430104 ([`ctg-observation-nct01430104-2013-01-14-8c7c875cf166`](#source-ctg-observation-nct01430104-2013-01-14-8c7c875cf166))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01430104 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-01-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01430104-2013-01-14-8c7c875cf166`](#source-ctg-observation-nct01430104-2013-01-14-8c7c875cf166))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01430104 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-01-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01430104-2013-01-14-8c7c875cf166`](#source-ctg-observation-nct01430104-2013-01-14-8c7c875cf166))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01430104-2013-01-14-8c7c875cf166`](#source-ctg-observation-nct01430104-2013-01-14-8c7c875cf166))

## Sources

<a id="source-ctg-observation-nct01430104-2013-01-14-8c7c875cf166"></a>
- **ClinicalTrials.gov record NCT01430104 · retained source version 2013-01-14:8c7c875cf166b0894257741518712245982d914a95ef313bc5b3de88781afbe7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01430104) (`ctg-observation-nct01430104-2013-01-14-8c7c875cf166`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01430104." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01430104-teriparatide-v1.json SHA-256: 43e0fdb06dec61d0527694f79c4aa249dc2239e99efeed0352fa8f2f73d39854.